title: Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
abstract: Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor (PPAR)-γ agonists commonly used as insulin-sensitizing drugs for the treatment of type 2 diabetes. In the last decade, PPAR-γ agonists have received increasing attention for their neuroprotective properties displayed in a variety of neurodegenerative diseases, including Parkinson's disease (PD), likely related to the anti-infammatory activity of these compounds. Recent studies indicate that neuroinflammation, specifically reactive microglia, plays important roles in PD pathogenesis. Moreover, after the discovery of infiltrating activated Limphocytes in the substantia nigra (SN) of PD patients, most recent research supports a role of immune-mediated mechanisms in the pathological process leading to chronic neuroinflammation and dopaminergic degeneration. PPAR-γ are highly expressed in cells of both central and peripheral immune systems, playing a pivotal role in microglial activation as well as in monocytes and T cells differentiation, in which they act as key regulators of immune responses. Here, we review preclinical evidences of PPAR-γ-induced neuroprotection in experimental PD models and highlight relative anti-inflammatory mechanisms involving either central or peripheral immunomodulatory activity. Specific targeting of immune functions contributing to neuroinflammation either directly (central) or indirectly (peripheral) may represent a novel therapeutic approach for disease modifying therapies in PD.
authors: Department of Toxicology, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.
authors: Anna R
authors: AR
authors: Carta
authors: Augusta
authors: A
authors: Pisanu
authors: Ezio
authors: E
authors: Carboni
references: Nat Med. 1999 Dec;5(12):1403-9
references: 10581083
references: J Immunol. 2000 Feb 1;164(3):1364-71
references: 10640751
references: J Pharmacol Exp Ther. 2007 Mar;320(3):1002-12
references: 17167171
references: J Biol Chem. 2005 Jun 3;280(22):21453-62
references: 15817469
references: Parkinsonism Relat Disord. 2008;14 Suppl 2:S124-9
references: 18595767
references: Exp Neurol. 2007 Jun;205(2):295-312
references: 17433296
references: J Neurochem. 2006 Apr;97(2):435-48
references: 16539667
references: Brain. 2008 Jul;131(Pt 7):1880-94
references: 18504291
references: Eur J Neurosci. 2008 Nov;28(9):1786-94
references: 18973594
references: Curr Opin Neurol. 2001 Aug;14(4):483-9
references: 11470965
references: Life Sci. 2007 Aug 23;81(11):906-15
references: 17765929
references: Lancet Neurol. 2009 Apr;8(4):382-97
references: 19296921
references: Physiol Behav. 2009 Aug 4;98(1-2):130-8
references: 19410592
references: Trends Neurosci. 2005 Nov;28(11):571-3
references: 16165228
references: Nature. 2005 Sep 29;437(7059):759-63
references: 16127449
references: Neurobiol Dis. 2010 Mar;37(3):630-40
references: 19969084
references: Eur J Neurosci. 2003 Nov;18(10):2731-42
references: 14656322
references: J Immunol. 2010 Mar 1;184(5):2261-71
references: 20118279
references: Neurosci Lett. 1994 Jan 3;165(1-2):208-10
references: 8015728
references: Neurosci Lett. 2008 Feb 27;432(3):198-201
references: 18207323
references: Parkinsonism Relat Disord. 2005 Dec;11(8):493-8
references: 16154792
references: Cell Metab. 2007 Aug;6(2):137-43
references: 17681149
references: Glia. 2007 Apr 1;55(5):453-62
references: 17203472
references: J Neurosci Res. 2008 Apr;86(5):1132-41
references: 18074385
references: Mol Cell Neurosci. 2005 Jul;29(3):381-93
references: 15890528
references: N Engl J Med. 2006 Dec 7;355(23):2427-43
references: 17145742
references: Neuroscience. 2005;130(3):685-96
references: 15590152
references: Endocr Rev. 1999 Oct;20(5):649-88
references: 10529898
references: Trends Neurosci. 1996 Aug;19(8):312-8
references: 8843599
references: Curr Pharm Des. 2006;12(1):93-109
references: 16454728
references: Annu Rev Immunol. 2009;27:119-45
references: 19302036
references: Lancet. 2005 Oct 8;366(9493):1279-89
references: 16214598
references: Mov Disord. 2007 Sep;22 Suppl 17:S335-42
references: 18175394
references: Biochem Biophys Res Commun. 2010 Apr 9;394(3):811-6
references: 20233578
references: Eur J Neurosci. 2000 Jul;12(7):2215-23
references: 10947800
references: Cell Biochem Biophys. 2000;32 Spring:187-204
references: 11330046
references: Biochim Biophys Acta. 2007 Aug;1771(8):926-35
references: 17433773
references: Arch Intern Med. 2010 Jul 26;170(14):1191-1201
references: 20656674
references: Lancet. 2006 Sep 23;368(9541):1096-105
references: 16997664
references: Brain Res. 2000 Jun 9;867(1-2):115-21
references: 10837804
references: FASEB J. 2006 Apr;20(6):670-82
references: 16581975
references: Neuroimmunomodulation. 1996 Mar-Jun;3(2-3):131-4
references: 8945728
references: J Immunol. 2002 Mar 15;168(6):2795-802
references: 11884448
references: Mov Disord. 2008 Mar 15;23(4):474-83
references: 18044695
references: Arch Neurol. 2001 Oct;58(10):1580-3
references: 11594915
references: Brain Behav Immun. 2009 Jan;23(1):55-63
references: 18678243
references: Science. 2010 Nov 5;330(6005):783-8
references: 21051630
references: Vasc Health Risk Manag. 2009;5(1):141-51
references: 19436665
references: Endocrinology. 1996 Jan;137(1):354-66
references: 8536636
references: J Neurochem. 2007 Mar;100(5):1375-86
references: 17254027
references: J Leukoc Biol. 2007 Nov;82(5):1083-94
references: 17675560
references: Mol Endocrinol. 2004 Jun;18(6):1321-32
references: 15087471
references: Nat Rev Immunol. 2010 May;10(5):365-76
references: 20414208
references: J Neuroimmunol. 2007 Dec;192(1-2):89-98
references: 17976742
references: Nat Clin Pract Neurol. 2007 Sep;3(9):496-504
references: 17805244
references: Nature. 1998 Jan 1;391(6662):79-82
references: 9422508
references: Prog Neurobiol. 2009 Nov;89(3):277-87
references: 19686799
references: N Engl J Med. 2007 Jun 14;356(24):2457-71
references: 17517853
references: Eur J Neurosci. 2002 Mar;15(6):991-8
references: 11918659
references: FASEB J. 2003 Mar;17(3):500-2
references: 12631585
references: J Clin Invest. 2009 Jan;119(1):182-92
references: 19104149
references: Science. 2010 Nov 5;330(6005):841-5
references: 20966214
references: Acta Neurol Scand. 1999 Jul;100(1):34-41
references: 10416510
references: Immunopharmacology. 1998 Jun;39(3):167-80
references: 9754903
references: Circulation. 2003 Dec 9;108(23):2941-8
references: 14662691
references: Neurotox Res. 2009 Aug;16(2):127-39
references: 19526289
references: Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H656-63
references: 20622108
references: Exp Neurol. 2002 Aug;176(2):322-7
references: 12359173
references: Brain. 2005 Nov;128(Pt 11):2665-74
references: 16219675
references: Trends Immunol. 2007 Dec;28(12):551-8
references: 17981503
references: Biomarkers. 2008 Sep;13(6):618-36
references: 18830857
references: Nature. 1998 Jan 1;391(6662):82-6
references: 9422509
references: Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):717-26
references: 12006382
references: Med Res Rev. 2001 May;21(3):185-210
references: 11301410
references: FEBS Lett. 2008 Jan 9;582(1):106-16
references: 18022390
references: Acta Neurobiol Exp (Wars). 1999;59(1):1-8
references: 10230070
references: J Biol Chem. 1997 Feb 7;272(6):3406-10
references: 9013583
references: Neurology. 1988 Aug;38(8):1285-91
references: 3399080
references: J Alzheimers Dis. 2008 Jul;14(3):301-11
references: 18599956
references: Neurosci Lett. 1994 Oct 24;180(2):147-50
references: 7700568
references: J Neuroinflammation. 2008 Jan 18;5:4
references: 18205920
references: Acta Neuropathol. 1992;84(1):100-4
references: 1502878
references: Neurosci Lett. 2007 Feb 27;414(1):94-7
references: 17196747
references: J Immunol. 2009 Apr 1;182(7):4137-49
references: 19299711
references: Biochem Biophys Res Commun. 2009 Aug 28;386(3):459-62
references: 19527689
references: J Neurochem. 2004 Jan;88(2):494-501
references: 14690537
references: Eur J Neurosci. 2009 Mar;29(5):954-63
references: 19245367
references: PPAR Res. 2008;2008:864140
references: 18464925
references: J Cereb Blood Flow Metab. 2006 Feb;26(2):218-29
references: 16034372
references: J Neurosci. 2005 Mar 9;25(10):2566-75
references: 15758166
references: Mol Cell. 1999 Oct;4(4):611-7
references: 10549292
references: Neuroscience. 2005;130(2):325-37
references: 15664689
references: Int Immunol. 2009 May;21(5):489-98
references: 19261692
references: Neuroscience. 2000;95(2):425-32
references: 10658622
references: Nat Neurosci. 2005 Jun;8(6):752-8
references: 15895084
references: J Neurosci. 1999 May 1;19(9):3440-7
references: 10212304
references: Am J Cardiol. 2002 Nov 1;90(9):947-52
references: 12398960
references: J Neurochem. 2007 Oct;103(1):67-76
references: 17573821
references: Lancet. 2009 Jun 20;373(9681):2125-35
references: 19501900
references: Br J Pharmacol. 2008 May;154(1):226-33
references: 18332857
references: Neurodegeneration. 1996 Jun;5(2):137-43
references: 8819134
references: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7531-6
references: 9207126
references: J Exp Med. 2009 Sep 28;206(10):2079-89
references: 19737866
references: Neurosci Lett. 1995 Dec 29;202(1-2):17-20
references: 8787820
references: J Neurochem. 2005 Mar;92(5):997-1009
references: 15715651
references: J Neurochem. 1998 Apr;70(4):1366-75
references: 9523552
references: Neurobiol Aging. 2009 Jun;30(6):920-31
references: 17950491
references: Expert Opin Drug Saf. 2008 Jul;7(4):367-76
references: 18613801
references: Horm Res. 2000;54(5-6):275-80
references: 11595817
references: Neuroimmunomodulation. 2011;18(2):79-88
references: 20938211
references: Exp Neurol. 2005 Feb;191(2):331-6
references: 15649489
references: Trends Neurosci. 2006 Feb;29(2):68-74
references: 16406093
references: J Neurochem. 2002 Aug;82(3):615-24
references: 12153485
references: Arterioscler Thromb Vasc Biol. 2008 May;28(5):932-9
references: 18292390
references: J Neurosci. 2000 Jan 15;20(2):558-67
references: 10632585
references: PPAR Res. 2007;2007:29275
references: 18060014
references: FASEB J. 2005 Apr;19(6):533-42
references: 15791003
references: Neuroscience. 2004;123(1):131-45
references: 14667448
references: J Am Coll Cardiol. 2007 Apr 24;49(16):1696-704
references: 17448371
references: Neuroscience. 2007 Mar 16;145(2):654-68
references: 17258864
references: Annu Rev Pharmacol Toxicol. 2006;46:1-39
references: 16402897
references: Cardiovasc Diabetol. 2008 Apr 24;7:10
references: 18435852
references: J Immunol. 2007 Feb 1;178(3):1904-13
references: 17237441
references: Science. 2005 May 27;308(5726):1314-8
references: 15831717